Latest High-intensity focused ultrasound Stories
Company on Track to Launch Phase III OPTIMA Study in Second Quarter LAWRENCEVILLE, N.J., May 8, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development
When cancer progresses and spreads to the bone, patients often suffer debilitating pain.
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Data Supports Development as Non-Invasive Treatment Regimen in a Variety of Cancer Indications LAWRENCEVILLE, N.J., April 9, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN)
Newer treatment options are expanding the clinical focus of cosmetic surgeries from the face to other areas of the body LONDON, April 9, 2014 /PRNewswire/ -- Aesthetic procedures,
The diagnostic and therapeutic ultrasound segments consist of highly advanced technologies used for imaging and treating a variety of medical conditions.
Strong demand for minimally invasive ablative therapies results in four HIFU device sales in first quarter of 2014 CHARLOTTE, N.C., April 2, 2014 /PRNewswire/ -- SonaCare Medical,
The use of a new technology called High Intensity Focused Ultrasound (HIFU) waves to treat prostate cancer without surgery on an out-patient basis moves closer to U.S. approval thanks to Dr.
Profound Medical announces initiation of U.S.
CHARLOTTE, N.C., Feb.